BTS ORAL POWDER

Land: Australien

Sprog: engelsk

Kilde: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktiv bestanddel:

BROMHEXINE HYDROCHLORIDE; TRIMETHOPRIM; SULFADIMIDINE

Tilgængelig fra:

JUROX PTY LIMITED

INN (International Name):

sulfadimidine(430mg/g)+trimethoprim(86mg/g)+bromhexine HCl(8.6mg/g)

Lægemiddelform:

ORAL POWDER, PRE-MIX

Sammensætning:

BROMHEXINE HYDROCHLORIDE GUANIDINE Active 8.6 mg/g; TRIMETHOPRIM PYRIMIDINE Active 86.0 mg/g; SULFADIMIDINE SULFANYL Active 430.0 mg/g

Enheder i pakken:

500g

Klasse:

VM - Veterinary Medicine

Terapeutisk gruppe:

HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL

Terapeutisk område:

ANTIBIOTIC & RELATED

Terapeutiske indikationer:

ANTIBIOTIC - ANTI-INFECTIVE | ABRASIONS | ABSCESSES | AIRSACCULITIS | ANTISEPTIC | AVIAN MYCOPLASMAS | BLACKHEAD | BODY ODOURS | BOWED TENDONS | BROAD SPECTRUM | BURNS | COCCIDIOSIS | COLIFORM COMPLEX | CONJUNCTIVITIS | COWPOX | CRACKS | CRUSTS | DANDRUFF | DERMATOLOGICAL DISORDERS | DERMATOSIS | DRY SKIN | DYSENTERY | ECZEMA | ENDOMETRITIS | ENTERIC DISEASES | ENZOOTIC PNEUMONIA | FEED EFFICIENCY | FUNGAL INFECTIONS | GIRTH GALLS | INFECTIONS | INFLAMMED PADS | ITCHING | KERATOLYTIC | LACERATIONS | MASTITIS | MYCOPLASMAS | ODOURS | OPEN WOUNDS | OTITIS | PRURITIS | QUEENSLAND ITCH | RESPIRATORY DISEASE | SADDLE RASH | SALMONELLOSIS | SCABS | SCALY SKIN | SHEATH ROT | SKIN IRRITATIONS | SORES | SWINE DYSENTERY | TEAT CRACKING | TEAT INFECTIONS | TOPICAL INFECTIONS | UDDER SORES | WEIGHT GAIN | WIRE CUTS | WOUNDS

Produkt oversigt:

Poison schedule: 4; Withholding period: WHP: Meat: Do not use less than 28 days before slaughter for human consumption .; Host/pest details: HORSE: [ANTIBIOTIC - ANTI-INFECTIVE]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [ANTIBIOTIC - ANTI-INFECTIVE]; Oral antibacterial and mucolytic for the treatment of respiratory disease in horses caused by organisms susceptible to sulfadimidine and trimethoprim, and where a mucolytic effect is desired.

Autorisation status:

Registered

Autorisation dato:

2023-07-01

Produktets egenskaber

BTS ORAL POWDER
Page 1 of 5
continued
ISSUED:
5 DECEMBER 2012
SAFETY DATA SHEET
SECTION 1: IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
PRODUCT NAME:
BTS ORAL POWDER
PRODUCT CODE:
501830 (500 g)
RECOMMENDED USE:
Oral antibacterial and mucolytic for use in the treatment of
respiratory
disease in horses
COMPANY IDENTIFICATION:
Jurox Pty Limited
ADDRESS:
85 Gardiner Street
Rutherford NSW 2320
Australia
CUSTOMER CENTRE:
1800 023 312
NATIONAL POISONS INFORMATION CENTRE:
131126 (Australia-wide)
EMERGENCY TELEPHONE NUMBER:
1800 023 312 (9a.m. – 5p.m.)
SECTION 2: HAZARDS IDENTIFICATION
GHS HAZARD CLASSIFICATIONS:
REPRODUCTIVE TOXICITY CATEGORY 2
SKIN SENSITIZER CATEGORY 1
GHS PICTOGRAMS*:
EXCLAMATION MARK
HEALTH HAZARD
SIGNAL WORD*:
WARNING
HAZARD STATEMENTS*:
May cause an allergic skin reaction.
Suspected of damaging fertility or the unborn child.
PRECAUTIONARY STATEMENTS*:
PREVENTION
Obtain special instructions before use.
Do not handle until all safety precautions have been read and
understood.
Avoid breathing dust.
Contaminated work clothing should not be allowed out of the workplace.
Wear protective gloves/protective clothing/eye protection/face
protection.
Use personal protective equipment as required.
RESPONSE
IF ON SKIN: Wash with plenty of soap and water.
IF exposed or concerned: Get medical advice.
If skin irritation or rash occurs: Get medical advice.
Take off contaminated clothing and wash it before reuse.
DISPOSAL
Dispose of contents / container in accordance with local / national
regulations.
* N.B.: These statements are determined by Work Health and Safety
regulations and may not reflect Signal Headings and
First Aid and Safety statements on product labelling, which are
determined by a competent authority during assessment
for registration.
BTS ORAL POWDER
Page 2 of 5
continued
SECTION 3: COMPOSITION / INFORMATION ON INGREDIENTS
INGREDIENT
CAS NO.
CONTENT
Sulfadimidine
57-68-1
43%
Trimethoprim
738-70-5
8.6%
Bromhexine hydrochloride
611-75-6
0.86%
Other ingredients determined to be not
hazardous
To 100%